G. Walmsley Graham - 13 Dec 2024 Form 4/A - Amendment Insider Report for Olema Pharmaceuticals, Inc. (OLMA)

Role: Director
Signature: /s/ Graham Walmsley
Issuer symbol: OLMA
Transactions as of: 13 Dec 2024
Net transactions value: $0
Form type: 4/A - Amendment
Filing time: 13 May 2025, 19:14:52 UTC
Date Of Original Report: 17 Dec 2024
Previous filing: 18 Jun 2024
Next filing: 07 Feb 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Graham G. Walmsley	Director	ONE SANSOME STREET, SUITE 1650, SAN FRANCISCO	/s/ Graham Walmsley	13 May 2025	0001777517

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	OLMA	Common Stock						1,800,000	13 Dec 2024	See note	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These securities are held by Logos Global Master Fund LP ("Logos Master Fund"). This holding was inadvertently omitted from the Form 4 filed by the reporting person on December 17, 2024. Logos Master Fund did not participate in the transactions reported in that Form 4. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.